Enterocolitis: Clinical Trials

26 trials for Enterocolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 4 unknown, 2 active not recruiting, 2 terminated. 26 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 326Completed 16, Unknown 4, Active not recruiting 2, Terminated 2, Not yet recruiting 1, Recruiting 1
Phase 23Active not recruiting 1, Completed 1, Unknown 1

Follow Enterocolitis: new trials by email Literature Review of Enterocolitis trials Research Report on Enterocolitis

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
Fidaxomicin, Vancomycin capsule - Clostridia Difficile Colitis
Phase 3RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre5002026-04-242026-09-23
Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants
Multi-strain probiotics - Necrotizing Enterocolitis (NEC)
Phase 3Not yet recruitingUniversity of Calgary21702025-06-012025-02-05
A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection
RBX2660 - Clostridium Difficile Infection Recurrence
Phase 3CompletedFerring Pharmaceuticals412023-04-212026-04-24
Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis
Pentoxifylline, Probiotic Formula - Necrotizing Enterocolitis
Phase 3CompletedTanta University752022-06-302024-05-20
Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion
Continuous amnioinfusion with Amnion Flush Solution through the intraamniotic catheter - Bronchopulmonary Dysplasia, Necrotizing Enterocolitis
Phase 3UnknownMartin-Luther-Universität Halle-Wittenberg682021-01-012021-01-12
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)
RBX2660 - Clostridium Difficile Infection, Infection
Phase 3CompletedRebiotix Inc.7932019-07-302024-08-07
IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study
IBP-9414, Placebo - Necrotizing Enterocolitis
Phase 3Active not recruitingInfant Bacterial Therapeutics21582019-07-042024-04-12
Human Milk Fortification in Extremely Preterm Infants
H2MF, Bovine milk-based fortifier - Necrotizing Enterocolitis, Sepsis
Phase 2 / Phase 3Active not recruitingThomas Abrahamsson, MD, PhD2292019-02-012024-07-23
Bovine Lactoferrin and Neonatal Survival in Low Birth Weight Babies.
bLF (Bovine lactoferrin), Glucon-D 99.4% (Placebo) - Neonatal Sepsis, Necrotizing Enterocolitis
Phase 3UnknownAga Khan University3002018-05-012020-04-09
Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)
RBX2660, Placebo, Open label RBX2660 (only for confirmed CDI recurrence) - Clostridium Difficile Infection (CDI)
Phase 3CompletedRebiotix Inc.3202017-07-312024-07-10
The Efficacy of Symbiotic on Cytokines
distilled water, symbiotic - Necrotising Enterocolitis
Phase 3CompletedZeynep Kamil Maternity and Pediatric Research and Training Hospital702013-07-012014-08-08
Role of Probiotics for Prevention of NEC in Preterm VLBW Infants
Probiotics, Breast milk - Necrotizing Enterocolitis
Phase 3CompletedSylhet M.A.G.Osmani Medical College602012-07-012016-01-08
Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants
Lactobacillus reuteri, Placebo - Necrotizing Enterocolitis, Very Low Birth Weight Infants
Phase 3CompletedZekai Tahir Burak Women's Health Research and Education Hospital4002012-02-012013-05-13
Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature Infants
Probiotic, Placebo - Necrotizing Enterocolitis
Phase 3CompletedUniversity of Stellenbosch1842011-07-012013-07-22
Effect of L-arginine and Glutamine on Preterm
Glutamine, l-arginine - NEC, Sepsis
Phase 2 / Phase 3CompletedAin Shams University752011-05-012014-04-15
Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants
Saccharomyces boulardii, Placebo - Necrotizing Enterocolitis, Very Low Birth Weight Infants
Phase 3UnknownZekai Tahir Burak Women's Health Research and Education Hospital2202011-02-012011-08-08
Prophylactic Probiotics in Premature Infants
Lactobacillus reuteri, Placebo - Death, Nosocomial Infection
Phase 3TerminatedColombian Neonatal Research Network7512008-08-012011-06-22
A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea
GT267-004 (tolevamer potassium sodium) - Enterocolitis, Pseudomembranous, Diarrhea
Phase 3TerminatedGenzyme, a Sanofi Company652007-04-012015-03-19
Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis
Vitamin A - Sepsis, Necrotizing Enterocolitis
Phase 3CompletedJohns Hopkins University4242006-12-012013-09-25
Cysteine Supplementation in Critically Ill Neonates
Parenteral cysteine-HCl supplementation, Placebo - added premasol - Sepsis, Bronchopulmonary Dysplasia
Phase 2 / Phase 3UnknownUniversity of California, Los Angeles1082006-09-012010-02-26

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Enterocolitis, Necrotizing (17)  ·  Enterocolitis, Pseudomembranous (9)  ·  Diarrhea (5)  ·  Sepsis (4)  ·  Bronchopulmonary Dysplasia (2)  ·  Clostridium Infections (2)  ·  Cross Infection (2)  ·  Premature Birth (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Communicable Diseases (1)  ·  Death (1)  ·  Ductus Arteriosus, Patent (1)  ·  Dysentery (1)  ·  Infections (1)  ·  Intracranial Hemorrhages (1)

Broader conditions

Digestive System Diseases (26)  ·  Gastroenteritis (26)  ·  Gastrointestinal Diseases (26)  ·  Intestinal Diseases (26)  ·  Infections (16)  ·  Pathological Conditions, Signs and Symptoms (13)  ·  Bacterial Infections (9)  ·  Bacterial Infections and Mycoses (9)  ·  Gram-Positive Bacterial Infections (9)  ·  Pathologic Processes (9)  ·  Clostridium Infections (7)  ·  Inflammation (5)  ·  Signs and Symptoms (5)  ·  Signs and Symptoms, Digestive (5)

Interventions

Probiotics (3)  ·  Arginine (1)  ·  Fidaxomicin (1)  ·  Glutamine (1)  ·  Indomethacin (1)  ·  Metronidazole (1)  ·  Milk, Human (1)  ·  Pentoxifylline (1)  ·  Rifampin (1)  ·  Saline Solution (1)  ·  Single Person (1)  ·  Vancomycin (1)  ·  Vitamin A (1)  ·  amino-acid, glucose, and electrolyte solution (1)  ·  nitazoxanide (1)

Sponsors

Genzyme, a Sanofi Company (3)  ·  Rebiotix Inc. (2)  ·  Zekai Tahir Burak Women's Health Research and Education Hospital (2)  ·  Aga Khan University (1)  ·  Ain Shams University (1)  ·  Colombian Neonatal Research Network (1)  ·  Daniel M. Musher MD (1)  ·  Ferring Pharmaceuticals (1)  ·  Infant Bacterial Therapeutics (1)  ·  Johns Hopkins University (1)  ·  King Chulalongkorn Memorial Hospital (1)  ·  Martin-Luther-Universität Halle-Wittenberg (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  McMaster University (1)  ·  NICHD Neonatal Research Network (1)

Countries

United States (9)  ·  Canada (6)  ·  Turkey (Türkiye) (3)  ·  Egypt (2)  ·  France (2)  ·  Germany (2)  ·  Spain (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Colombia (1)

Top investigators

Teena Chopra, M.D., M.P.H. (2)  ·  Almas Aamir, MSC (1)  ·  Avroy A. Fanaroff, MD (1)  ·  Barbara J. Stoll, MD (1)  ·  Barbara Schmidt, MD (1)  ·  Charles R. Bauer, MD (1)  ·  Christian L Coles, PhD (1)  ·  Christine H Lee, MD (1)  ·  Daniel M Musher, M.D. (1)  ·  David K. Stevenson, MD (1)  ·  Emily McDonald, MD MSc (1)  ·  Evette van Niekerk, M Dietetics (1)  ·  Fahri Ovali (1)  ·  GHada A. Saleh, MRCPCH (1)

Results publications

PMID 42286373, PMID 24799326, PMID 41245385, PMID 11430325, PMID 12622582, PMID 16647401, PMID 16769377, PMID 17188612, PMID 17307535, PMID 17636753, PMID 18245398, PMID 19117897, PMID 21727276, PMID 23071204, PMID 24309022, PMID 24919691, PMID 25861285, PMID 28710882, PMID 33006765, PMID 33058137, PMID 33704071, PMID 34815288, PMID 36143388, PMID 36287379, PMID 37493095, PMID 37564743, PMID 38236515, PMID 38545091, PMID 38556499, PMID 39172632, PMID 39180326, PMID 40177588, PMID 40321366, PMID 40348496, PMID 40552763, PMID 40672762, PMID 40784972, PMID 41115624, PMID 41230019, PMID 41647268, PMID 41653256, PMID 42840322

NIH funding

K01DK075478 (1), K08HD052885 (1), M01RR000070 (1), M01RR000997 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1), U10HD027851 (1), U10HD027880 (1), U10HD027881 (1), U10HD027904 (1), U10HD034216 (1)